Friday , April 3 2026

Marketing application of BOGUTAI® (teriparatide injection) has been officially accepted by the China National Medical Products Administration (NMPA)

HONG KONG SAR – EQS Newswire – 29 June 2022 – A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited (the “Company”, together with its subsidiaries, the “Group”; Stock code: 00690.HK) is pleased to announce that t the marketing application submitted by the Group’s self-developed BOGUTAI® (teriparatide injection) has …

Read More »